Marina Ricci

Marina Ricci is a Biology Scientist at Merck Group, contributing to the Cell Based Assay Laboratory since March 2020, following roles as a Biology Associate Scientist and Associate Researcher in the same laboratory. Prior to joining Merck, Marina completed a postdoctoral fellowship at Università degli Studi di Padova, focusing on the "Role of IDI1 and Mevalonate Pathway in Breast Cancer" under the guidance of Prof. Massimo Santoro. Additional experience includes a period as a Visiting PhD Student at the University of California, Davis, and involvement in various research fellowships and internships at institutions including Università degli Studi del Piemonte Orientale, Universitat de Barcelona, and Università degli Studi di Torino. Marina Ricci holds a PhD in Experimental Medicine and Therapy, a Master of Laws in Cellular and Molecular Biology, and a Bachelor of Laws in Biology, all obtained from Università degli Studi di Torino.